Hamm Robert A 4
4 · BIOGEN IDEC INC. · Filed Feb 19, 2010
Insider Transaction Report
Form 4
BIOGEN IDEC INC.BIIB
Hamm Robert A
EVP, Pharma. Oper. & Tech.
Transactions
- Sale
Common Stock
2010-02-18$56.15/sh−3,194$179,358→ 26,333.41 total - Sale
Common Stock
2010-02-18$56.16/sh−3,387$190,198→ 22,946.41 total
Footnotes (4)
- [F1]Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
- [F3]This represents the weighted average price for shares sold at a range between $55.90 (low) and $56.29 (high).
- [F4]This represents the weighted average price for shares sold at a range between $55.90 (low) and $56.33 (high).